Although previous studies have mentioned its involvement in brain tumors such as neuroblastoma (Mohlin et al., 2015) and GBM (Wang et al., 2018), few studies focused on the roles of EPAS1 in GBM invasion. Here, EPAS1 is linked to brain neoplasm.